EPL Ltd

- There is no specific mention of any current or planned new fundraising through debt or equity in the transcript. - The company is focused on gradual reduction of debt and prioritizes growth investments. - Debt and interest costs may fluctuate due to phasing and accelerated CAPEX but no fresh fundraising is indicated. - Management emphasizes sustained double-digit revenue growth funded by internal resources. - M&A opportunities are being actively pursued, but no concrete plans or fundraising linked to M&A were disclosed.

- EPL Limited is actively investing in extruded capacity, particularly in the Beauty & Cosmetics (B&C) segment, to support high growth. - A new manufacturing plant in Thailand was commercialized recently (November of the reported quarter) and is currently scaling up. - The company follows an investment philosophy of aligning capital expenditure with depreciation, ensuring depreciation growth remains lower than revenue growth. - They continue to make capital investments that support sustainable double-digit revenue growth and margin expansion. - EPL is building front-end and back-end capabilities, including a center of excellence in Mumbai focused on innovation, proofing, and sampling. - The company is exploring M&A opportunities that offer new geographical presence or new capabilities, with criteria focusing on margin and growth accretiveness, although no concrete deals are currently announced. - Overall, EPL prioritizes growth investments while maintaining margin discipline and capital efficiency.

- EPL Limited expects sustained double-digit revenue growth over the next 5 years. - Beauty & Cosmetics segment is targeted to grow at a high teen percentage rate, reflecting significant headroom and strategic focus. - Oral care and pharma segments are expected to grow steadily but at a comparatively moderate pace. - Continuous investments in innovation, extruded capacity, and front-end/back-end capabilities support this growth trajectory. - Emerging markets like Thailand and Brazil are key growth drivers, with organic scaling expected in Thailand. - The company remains open to M&A opportunities that extend geographic reach or build new capabilities aligned with growth and margin accretion. - Overall, ESL aims to prioritize growth over other metrics, targeting EBITDA growth slightly ahead of revenue growth. - The goal includes strengthening market share, especially in Beauty & Cosmetics, and achieving operational efficiencies contributing to growth.

- EPL Limited expects sustained double-digit revenue growth over the next 5 years (Page 16). - Beauty & Cosmetics segment targeted for high teen percentage growth in topline (Page 16). - EBITDA growth anticipated to be slightly ahead of revenue growth, emphasizing margin improvement (Pages 10, 14). - ROCE targets an expansion from 18% to 25%, driven by both margin improvement and capital efficiency (Page 14). - The company prioritizes growth over other metrics but aims to grow EBITDA slightly ahead of revenue (Page 14). - Proactive margin management processes have been implemented to protect margins amid commodity cycles (Page 16). - Margin expansion initiatives and operational efficiencies are ongoing, especially in Europe, aiming to return to mid-teen margins (Page 9). - The overall strategy is focused on profitable, sustainable growth with strong cash flow and ROCE improvement (Page 5).

- The transcript does not provide specific details on the current or expected order book or pending orders for EPL Limited. - However, Hemant Bakshi mentioned a "really strong and healthy pipeline" of business in Thailand, indicating promising future orders in that geography. - The company is focused on scaling up operations in new markets like Thailand, though commercial operations there started recently. - The management highlighted ongoing efforts to acquire and retain customers, especially in the Beauty & Cosmetics segment, which has many more customers compared to Oral care. - Growth and order inflows appear strong in Beauty & Cosmetics and China regions, reflecting positive demand momentum. - No quantitative figures or specific order backlog numbers were disclosed in the transcript.